Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...

The FDA has approved a new drug called revumenib that can be taken orally to treat acute leukemia in patients 1 year or older. The drug will be marketed under the brand name Revuforj.

Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.

Patients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are ...

The invention uses light, sound and bubbles to quickly create copies of soft tissue that might one day support testing individualized therapies for cancer and other diseases ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin that drives childbirth contractions.

OCON Therapeutics invented a novel technology that allows for intrauterine drug delivery that could affect the wellbeing of ...